After a century of false starts, scientists believe they have found a way to make cells burn more energy without the ...

Bitcoin Hyper is a new crypto project that aims to facilitate faster, lower-cost Bitcoin transfers. HYPER is in the presale phase and can be purchased via the official website or a crypto launchpad.

The growing ubiquity of artificial intelligence remains a divisive topic among the public, but the White House is fully leaning into the AI boom. President Donald Trump has announced the creation of a ...

The New York Post may receive revenue from affiliate/advertising partnerships for sharing this content and/or if you click or make a purchase. Bitcoin Hyper is one of the latest speculative tokens ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook One of Dragon Ball Z’s most iconic moments has been turned into a pretty awesome pair of Funko ...

Dylan Field is the CEO of Figma, a $19.45 billion design tool company used by 95% of the Fortune 500. Before co-founding Figma in 2012, he had no experience being a manager. Field describes himself as ...

Equity investors are growing increasingly concerned about the amount of leverage that Big Tech is taking on to build out its artificial intelligence infrastructure as the industry faces rising fears ...

BOSTON — Nov. 20, 2025 — Ginkgo Bioworks (NYSE: DNA) today announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to ...

ST. JOHNS COUNTY, Fla. – The appeal for a cell tower permit was denied during Tuesday’s St. Johns County Commission meeting. The planning and zoning agency already denied the permit in July to build ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while strengthening its prostate cancer franchise built on Erleada. At the center of the ...

Electricity demand is surging, driven by artificial intelligence and a boom in data center construction. Some warn the U.S. grid can’t keep up. But Scott Strazik, CEO of GE Vernova, says his company ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...